drugset / Trial / NCT05926765
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will assess the efficacy and safety of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.
Timeline
- Start
- 2023-06-13
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AAV2hAQP1 | Gene therapy (AAV / viral vector) | — | Other |
Indications
No indication recorded.